Items where City Author is "Emerson, Lydia"
Article
Aitken, L. M. 
ORCID: 0000-0001-5722-9090, Emerson, L. M. ORCID: 0000-0002-4250-5758, Kydonaki, K. , Blackwood, B., Creagh-Brown, B., Lone, N. I., McKenzie, C. A., Reade, M. C., Weir, C. J., Wise, M. P. & Walsh, T. S. (2024).
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B trial): protocol for a mixed-methods process evaluation of a randomised controlled trial.
BMJ Open, 14(4),
article number e081637.
doi: 10.1136/bmjopen-2023-081637
Walsh, T. S., Aitken, L. M. ORCID: 0000-0001-5722-9090, McKenzie, C. A. , Boyd, J., Macdonald, A., Giddings, A., Hope, D., Norrie, J., Weir, C., Parker, R. A., Lone, N. I., Emerson, L. M. ORCID: 0000-0002-4250-5758, Kydonaki, K., Creagh-Brown, B., Morris, S., McAuley, D. F., Dark, P., Wise, M. P., Gordon, A. C., Perkins, G., Reade, M., Blackwood, B., MacLullich, A., Glen, R. & Page, V. J. (2023).
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK.
BMJ Open, 13(12),
article number e078645.
doi: 10.1136/bmjopen-2023-078645
Eadie, R., McKenzie, C., Blackwood, B. , Emerson, L. M. ORCID: 0000-0002-4250-5758, Aitken, L., Boyd, J. & Walsh, T. (2022).
Clinical pharmacist’s views on the role of alpha-2-agonists in practice and research for the management of agitation, sedation and delirium (ASD).
Journal of the Intensive Care Society, 23(1),
doi: 10.1177/17511437221095122
Silversides, J. A., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758 , Bradbury, I., Bannard-Smith, J., Szakmany, T., Trinder, J., Rostron, A. J., Johnston, P., Ferguson, A. J., Boyle, A. J., Blackwood, B., Marshall, J. C. & McAuley, D. F. (2022).
Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial.
Intensive Care Medicine, 48(2),
pp. 190-200.
doi: 10.1007/s00134-021-06596-8
Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N. H., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O’Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A. M., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J. (2020).
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumonia.
Annals of Translational Medicine, 8(13),
article number 840.
doi: 10.21037/atm-20-3701
Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O'Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J. (2019).
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation.
The Lancet Respiratory Medicine, 8(2),
pp. 182-191.
doi: 10.1016/s2213-2600(19)30367-4
Richards-Belle, A., Mouncey, P. R., Wade, D. , Brewin, C. R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Grieve, R., Harrison, D., Harvey, S., Howell, D., Mythen, M., Sadique, Z., Smyth, D., Weinman, J., Welch, J. & Rowan, K. M. (2018).
Psychological Outcomes following a nurse-led Preventative Psychological Intervention for critically ill patients (POPPI): protocol for a cluster-randomised clinical trial of a complex intervention.
BMJ Open, 8(2),
article number e020908.
doi: 10.1136/bmjopen-2017-020908
Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J. (2016).
Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
Trials, 17(1),
article number 318.
doi: 10.1186/s13063-016-1442-x
Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J. (2016).
Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’.
Trials, 17(1),
article number 465.
doi: 10.1186/s13063-016-1594-8
Mouncey, P. R., Wade, D., Richards-Belle, A. , Sadique, Z., Wulff, J., Grieve, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Brewin, C. R., Harvey, S., Howell, D., Hudson, N., Khan, I., Mythen, M., Smyth, D., Weinman, J., Welch, J., Harrison, D. & Rowan, K. M.
A nurse-led, preventive, psychological intervention to reduce PTSD symptom severity in critically ill patients: the POPPI feasibility study and cluster RCT.
Health Services and Delivery Research, 7(30),
pp. 1-174.
doi: 10.3310/hsdr07300
Conference or Workshop Item
Emerson, L. M. ORCID: 0000-0002-4250-5758, McAuley, D., Clarke, M. , Hellyer, T. P., Simpson, A. J. & Blackwood, B. (2017).
Developing a framework to aid purposive sampling in process evaluation of a critical care trial.
In:
Trials.
4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials, 7-10 May 2017, Liverpool, UK.
doi: 10.1186/s13063-017-1902-y